Article Text

other Versions


Antagonists and non-toxic variants of the dominant wheat gliadin T-cell epitope in coeliac disease

Statistics from

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview
  • Competing interests: RPA is a consultant to BTG International, and CSO to Nexpep Ltd, licensee of patents pertaining to the therapeutic and diagnostic use of gluten determinants.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.